North America Ophthalmic Drugs Market Forecast 2019-2027

Publisher Name :
Date: 10-Jun-2019
No. of pages: 80

KEY FINDINGS

North America ophthalmic drugs market was valued at $XX million in 2018 and is expected to reach $XX million by 2027 growing at a CAGR of 3.66% during the forecast period of 2019-2027. The ophthalmic drugs and devices market is driven by factors like increase in FDA approvals which gives a boost in the adoption of drugs and devices and rise in surgeries in ophthalmology market due to the high dominance of refractive errors.

MARKET INSIGHTS

The prevalence of blindness and vision impairment and other eye-related disorders is expected to increase rapidly among all age group, gender and racial group in North America. The increase in geriatric population, rise in the number of eye disorders, increase in healthcare expenditure and rise in adoption of minimally invasive surgeries have contributed to the growth of the market in North America.

Well-known drugs are going off patent and key players affected by the delay in new drugs coming into the market are the two factors restricting the growth of the market. The market faces challenges in risk associated with the ocular diseases and lack of awareness among people regarding ophthalmology.

COMPETITIVE INSIGHTS

Global ophthalmic drugs market has a large number of market players but the market is dominated by companies like Cipla Pharmaceuticals, Sun Pharmaceuticals Industries, Ltd., Valeant, Apollo Endosurgery, Bayer, Johnson and Johnson, Regeneron, Pfizer Inc., Eyegate Pharmaceuticals, Abbott Laboratories, Novartis AG, Roche Holding AG, Allergan Inc., Senju Pharmaceutical Co., Ltd., GlaxoSmithKline, and Merck & Co.

North America Ophthalmic Drugs Market Forecast 2019-2027

Table of Contents

1. Research Scope
1.1. Study Goals
1.2. Scope Of The Market Study
1.3. Who Will Find This Report Useful?
1.4. Study And Forecasting Years
2. Research Methodology
2.1. Sources Of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top-Down Approach
2.3. Bottom-Up Approach
2.4. Data Triangulation
3. Executive Summary
3.1. Market Summary
3.2. Key Findings
3.2.1. Retinal Disorders Are The Highest Revenue Generating Indication
3.2.2. Prescription Drugs Are The Fastest Growing Ophthalmic Drugs Type
3.2.3. Hospital Pharmacies Are The Majorly Used Distribution Channel
3.2.4. Liquid Ophthalmic Drug Forms Are The Widely Used Dosage Form
3.2.5. Anti-Allergy Therapeutic Class Is Anticipated To Grow At A Significant Rate During The Forecast Period
3.2.6. Small Molecule Technology Is Used For The Treatment Of Eye Diseases
4. Market Determinants
4.1. Market Definition And Scope
4.2. Market Drivers
4.2.1. Increasing Geriatric Population
4.2.2. Technological Advancement
4.2.3. Rising Prevalence Of Eye Disorders
4.2.4. Increased Healthcare Expenditure
4.3. Market Restraints
4.3.1. Renowned Drugs Going Off-Patent
4.3.2. Delay In Drug Approvals
4.4. Market Opportunities
4.4.1. Increase In Disorder Symptom And Improved Diagnosis Leading To Higher Treatment Rates
4.4.2. Growing Opportunities In Developing Economies
4.5. Market Challenges
4.5.1. Side Effects Related To The Ophthalmic Drugs
5. Market By Indication
5.1. Dry Eye
5.2. Glaucoma
5.3. Infection/Inflammation/Allergy
5.4. Retinal Disorders
5.4.1. Wet Age-Related Macular Degeneration
5.4.2. Dry Age-Related Macular Degeneration
5.4.3. Diabetic Retinopathy
5.4.4. Other Retinal Disorders
5.5. Other Indication
6. Market By Type
6.1. Prescription Drugs
6.2. Over-The-Counter Drugs
7. Market By Distribution Channel
7.1. Hospital Pharmacies
7.2. Drug Stores
7.3. Online Pharmacies
7.4. Other Distribution Channel
8. Market By Dosage Form
8.1. Liquid Ophthalmic Drug Forms
8.2. Solid Ophthalmic Drug Forms
8.3. Semisolid Ophthalmic Drug Forms
8.4. Multicompartment Drug Delivery Systems
8.5. Other Ophthalmic Drug Forms
9. Market By Therapeutic Class
9.1. Anti-Glaucoma
9.2. Anti-Infective
9.3. Anti-Inflammatory
9.4. Anti-Allergy
10. Market By Technology
10.1. Biologics
10.2. Cell Therapy
10.3. Gene Therapy
10.4. Drug Delivery
10.5. Small Molecule
10.6. Other Technology
11. Key Analytics
11.1. Porter's Five Forces Analysis
11.1.1. Bargaining Power Of Buyers
11.1.2. Bargaining Power Of Supplier
11.1.3. Threats Of New Entrants
11.1.4. Threats Of Substitutes
11.1.5. Competitive Rivalry
11.2. Value Chain Analysis
11.2.1. Research And Development
11.2.2. Manufacturing
11.2.3. Marketing And Distribution
11.3. Regulatory Framework
11.4. Opportunity Matrix
12. Geographical Analysis
12.1. North America
12.1.1. The United States
12.1.2. Canada
13. Company Profiles
13.1. Abbott Laboratories
13.2. Allergan Inc.
13.3. Johnson And Johnson
13.4. Bayer
13.5. Valeant
13.6. Regeneron
13.7. Pfizer Inc.
13.8. Merck & Co.
13.9. Novartis Ag
13.10. Glaxosmithkline
13.11. Eyegate Pharmaceuticals
13.12. Apollo Endosurgery
13.13. Roche Holding Ag
13.14. Cipla Pharmaceuticals
13.15. Senju Pharmaceutical Co., Ltd.
13.16. Sun Pharmaceuticals Industries, Ltd.

List of Tables

Table 1 North America Ophthalmic Drug Market Revenue 2019-2027 ($ Million)
Table 2 Common Causes Of Loss Of Vision In The Elderly
Table 3 Eye Drugs Gone Off-Patent
Table 4 North America Ophthalmic Drugs Market By Indication 2019-2027 ($ Million)
Table 5 North America Dry Eye Market 2019-2027 ($ Million)
Table 6 North America Ophthalmic Drugs Market By Dry Eye 2019-2027 ($ Million)
Table 7 North America Glaucoma Market 2019-2027 ($ Million)
Table 8 North America Infection/Inflammation/Allergy Market 2019-2027 ($ Million)
Table 9 North America Retinal Disorders Market 2019-2027 ($ Million)
Table 10 North America Wet Age-Related Macular Degeneration Market 2019-2027 ($ Million)
Table 11 North America Dry Age-Related Macular Degeneration Market 2019-2027 ($ Million)
Table 12 North America Diabetic Retinopathy Market 2019-2027 ($ Million)
Table 13 North America Other Retinal Disorders Market 2019-2027 ($ Million)
Table 14 North America Other Indication Market 2019-2027 ($ Million)
Table 15 North America Ophthalmic Drugs Market By Type 2019-2027 ($ Million)
Table 16 North America Prescription Drugs Market 2019-2027 ($ Million)
Table 17 North America Over-The-Counter Drugs Market 2019-2027 ($ Million)
Table 18 North America Ophthalmic Drugs Market By Distribution Channel 2019-2027 ($ Million)
Table 19 North America Hospital Pharmacies Market 2019-2027 ($ Million)
Table 20 North America Drug Stores Market 2019-2027 ($ Million)
Table 21 North America Online Pharmacies Market 2019-2027 ($ Million)
Table 22 North America Other Distribution Channel Market 2019-2027 ($ Million)
Table 23 North America Ophthalmic Drugs Market By Dosage Form 2019-2027 ($ Million)
Table 24 North America Liquid Ophthalmic Drug Forms Pharmacies Market 2019-2027 ($ Million)
Table 25 North America Solid Ophthalmic Drug Forms Market 2019-2027 ($ Million)
Table 26 North America Semisolid Ophthalmic Drug Forms Market 2019-2027 ($ Million)
Table 27 North America Multicompartment Drug Delivery Systems Market 2019-2027 ($ Million)
Table 28 North America Other Ophthalmic Drug Forms Market 2019-2027 ($ Million)
Table 29 North America Ophthalmic Drugs Market By Therapeutic Class 2019-2027 ($ Million)
Table 30 North America Anti-Glaucoma Market 2019-2027 ($ Million)
Table 31 North America Anti-Infective Market 2019-2027 ($ Million)
Table 32 North America Anti-Inflammatory Market 2019-2027 ($ Million)
Table 33 North America Anti-Allergy Market 2019-2027 ($ Million)
Table 34 North America Ophthalmic Drugs Market By Technology 2019-2027 ($ Million)
Table 35 North America Biologics Market 2019-2027 ($ Million)
Table 36 North America Cell Therapy Market 2019-2027 ($ Million)
Table 37 North America Gene Therapy Market 2019-2027 ($ Million)
Table 38 North America Drug Delivery Market 2019-2027 ($ Million)
Table 39 North America Small Molecule Market 2019-2027 ($ Million)
Table 40 North America Other Technology Market 2019-2027 ($ Million)
Table 41 North America Ophthalmic Drugs Market By Country 2019-2027 ($ Million)

List of Figures

Figure 1 North America Ophthalmic Drugs Market By Glaucoma 2019-2027 ($ Million)
Figure 2 North America Ophthalmic Drugs Market By Infection /Inflammation /Allergy 2019-2027 ($ Million)
Figure 3 North America Ophthalmic Drugs Market By Retinal Disorders 2019-2027 ($ Million)
Figure 4 North America Retinal Disorders Market By Wet Age-Related Macular Degeneration 2019-2027 ($ Million)
Figure 5 North America Retinal Disorders Market By Dry Age-Related Macular Degeneration 2019-2027 ($ Million)
Figure 6 North America Retinal Disorders Market By Diabetic Retinopathy 2019-2027 ($ Million)
Figure 7 North America Retinal Disorders Market By Other Retinal Disorders 2019-2027 ($ Million)
Figure 8 North America Ophthalmic Drugs Market By Other Indication 2019-2027 ($ Million)
Figure 9 North America Ophthalmic Drugs Market By Prescription Drugs 2019-2027 ($ Million)
Figure 10 North America Ophthalmic Drugs Market By Over-The-Counter Drugs 2019-2027 ($ Million)
Figure 11 North America Ophthalmic Drugs Market By Hospital Pharmacies 2019-2027 ($ Million)
Figure 12 North America Ophthalmic Drugs Market By Drug Stores 2019-2027 ($ Million)
Figure 13 North America Ophthalmic Drugs Market By Online Pharmacies 2019-2027 ($ Million)
Figure 14 North America Ophthalmic Drugs Market By Other Distribution Channel 2019-2027 ($ Million)
Figure 15 North America Ophthalmic Drugs Market By Liquid Ophthalmic Drug Forms 2019-2027 ($ Million)
Figure 16 North America Ophthalmic Drugs Market By Solid Ophthalmic Drug Forms 2019-2027 ($ Million)
Figure 17 North America Ophthalmic Drugs Market By Semisolid Ophthalmic Drug Forms 2019-2027 ($ Million)
Figure 18 North America Ophthalmic Drugs Market By Multicompartment Drug Delivery Systems 2019-2027 ($ Million)
Figure 19 North America Ophthalmic Drugs Market By Other Ophthalmic Drug Forms 2019-2027 ($ Million)
Figure 20 North America Ophthalmic Drugs Market By Anti-Glaucoma 2019-2027 ($ Million)
Figure 21 North America Ophthalmic Drugs Market By Anti-Infective 2019-2027 ($ Million)
Figure 22 North America Ophthalmic Drugs Market By Anti-Inflammatory 2019-2027 ($ Million)
Figure 23 North America Ophthalmic Drugs Market By Anti-Allergy 2019-2027 ($ Million)
Figure 24 North America Ophthalmic Drugs Market By Biologics 2019-2027 ($ Million)
Figure 25 North America Ophthalmic Drugs Market By Cell Therapy 2019-2027 ($ Million)
Figure 26 North America Ophthalmic Drugs Market By Gene Therapy 2019-2027 ($ Million)
Figure 27 North America Ophthalmic Drugs Market By Drug Delivery 2019-2027 ($ Million)
Figure 28 North America Ophthalmic Drugs Market By Small Molecule 2019-2027 ($ Million)
Figure 29 North America Ophthalmic Drugs Market By Other Technology 2019-2027 ($ Million)
Figure 30 The United States Population Ages 65 And Older, 1960 To 2060 (Million)
Figure 31 The United States Ophthalmic Drugs Market 2019-2027 ($ Million)
Figure 32 Canada Ophthalmic Drugs Market 2019-2027 ($ Million)
Figure 33 Prevalence Rate Of Retinal Disorders In Canada, 2016
  • Global Artificial Tears Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 91
    Artificial tears are lubricant eye drops used to treat The dryness and irritation associated with deficient tear production in keratoconjunctivitis sicca (dry eyes). They are also used to moisten contact lenses and in eye examinations. The global Artificial Tears market was valued at US$ 2921.6 million in 2023 and is anticipated to reach US$ 5240.1 million by 2030, witnessing a CAGR of 8.6% during The forecast period 2024-2030. The industry's leading producers are Aller......
  • Global Contact Lens Solution Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 96
    Contact lens solution is a kind of solution that is used to contact lens with The function of cleaning, disinfection, rinsing or preservation, it can also alleviate The eyeball discomfort which caused by wear The contact lens. Contact lens solution can direct contact eyeball, so it must be accord with industrial standard. The global Contact Lens Solution market was valued at US$ 4087.6 million in 2023 and is anticipated to reach US$ 5323.5 million by 2030, witnessing a CAGR of 3.8% ......
  • Global Latanoprost Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 82
    Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside The eye. Onset of effects is usually within four hours, and they last for up to a day. Latanoprost is used to treat high pressure inside The eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in The body (prostaglandin) and works by regulating The flow of fluid within The eye which results in lower pressure. Lowerin......
  • Global Contact Lens Solution Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 99
    Market Overview of Global Contact Lens Solution market: According to our latest research, the global Contact Lens Solution market looks promising in the next 5 years. As of 2022, the global Contact Lens Solution market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Contact ......
  • Global Dry Eye Syndrome Drugs Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The Dry Eye Syndrome Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dry Eye Syndrome Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive......
  • Global Eye Drops & Lubricants Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 112
    According to our LPI (LP Information) latest study, the global Eye Drops & Lubricants market size was valued at US$ 8841.8 million in 2023. With growing demand in downstream market, the Eye Drops & Lubricants is forecast to a readjusted size of US$ 9780.8 million by 2030 with a CAGR of 1.5% during review period. The research report highlights the growth potential of the global Eye Drops & Lubricants market. Eye Drops & Lubricants are expected to show stable growth in the future market. H......
  • Global Conjunctivitis Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 98
    According to our LPI (LP Information) latest study, the global Conjunctivitis market size was valued at US$ 3482.7 million in 2023. With growing demand in downstream market, the Conjunctivitis is forecast to a readjusted size of US$ 3908 million by 2030 with a CAGR of 1.7% during review period. The research report highlights the growth potential of the global Conjunctivitis market. Conjunctivitis are expected to show stable growth in the future market. However, product differentiation, r......
  • Global Contact Lens Solution Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 118
    According to our LPI (LP Information) latest study, the global Contact Lens Solution market size was valued at US$ 3998.7 million in 2023. With growing demand in downstream market, the Contact Lens Solution is forecast to a readjusted size of US$ 5241.5 million by 2030 with a CAGR of 3.9% during review period. The research report highlights the growth potential of the global Contact Lens Solution market. Contact Lens Solution are expected to show stable growth in the future market. Howev......
  • Global Latanoprost Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90
    According to our LPI (LP Information) latest study, the global Latanoprost market size was valued at US$ 1344.2 million in 2023. With growing demand in downstream market, the Latanoprost is forecast to a readjusted size of US$ 1574.2 million by 2030 with a CAGR of 2.3% during review period. The research report highlights the growth potential of the global Latanoprost market. Latanoprost are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs